The neisseria meningitidis CRISPR-Cas9 system enables specific genome editing in mammalian cells

183Citations
Citations of this article
281Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The clustered regularly-interspaced short palindromic repeats (CRISPR) - CRISPR-associated (Cas) system from Streptococcus pyogenes (Spy) has been successfully adapted for RNA-guided genome editing in a wide range of organisms. However, numerous reports have indicated that Spy CRISPR-Cas9 systems may have significant off-target cleavage of genomic DNA sequences differing from the intended on-target site. Here, we report the performance of the Neisseria meningitidis (Nme) CRISPR-Cas9 system that requires a longer protospacer-adjacent motif for site-specific cleavage, and present a comparison between the Spy and Nme CRISPR-Cas9 systems targeting the same protospacer sequence. The results with the native crRNA and tracrRNA as well as a chimeric single guide RNA for the Nme CRISPR-Cas9 system were also compared. Our results suggest that, compared with the Spy system, the Nme CRISPR-Cas9 system has similar or lower on-target cleavage activity but a reduced overall off-target effect on a genomic level when sites containing three or fewer mismatches are considered. Thus, the Nme CRISPR-Cas9 system may represent a safer alternative for precision genome engineering applications.

Cite

CITATION STYLE

APA

Lee, C. M., Cradick, T. J., & Bao, G. (2016). The neisseria meningitidis CRISPR-Cas9 system enables specific genome editing in mammalian cells. Molecular Therapy, 24(3), 645–654. https://doi.org/10.1038/mt.2016.8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free